Navidea Biopharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Navidea Biopharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 88% to $65,652. Profit margin reached -26222%. Total operating expenses were $13,931,600.
Profit Margin
| 2013 | 1.13M | -42.69M | -3776.61% |
|---|---|---|---|
| 2014 | 6.27M | -35.72M | -569.36% |
| 2015 | 13.24M | -27.56M | -208.03% |
| 2016 | 21.96M | -14.30M | -65.13% |
| 2017 | 1.81M | 74.94M | 4139.67% |
| 2018 | 322.52K | -16.12M | -5000.12% |
| 2019 | 26.61K | -10.94M | -41120.85% |
| 2020 | 915.01K | -10.63M | -1162.82% |
| 2021 | 531.51K | -11.73M | -2207.08% |
| 2022 | 65.65K | -17.21M | -26221.65% |
NAVB Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 65.65K | 531.51K | 915.01K | 26.61K | 322.52K | 1.81M | 21.96M | 13.24M | 6.27M | 1.13M |
Cost of revenue | 184.94K | 0 | 1.04K | 6.66K | 96.63K | 3.65K | 2.29M | 1.75M | 1.58M | 332.81K |
Gross profit | -119.29K | 531.51K | 913.96K | 19.95K | 225.88K | 1.80M | 19.67M | 11.49M | 4.68M | 797.81K |
Operating exp. | ||||||||||
Research and development | 5.96M | 5.14M | 4.93M | 5.33M | 4.22M | 4.51M | 8.88M | 12.78M | 16.77M | 23.71M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 13.93M | 12.59M | 11.62M | 10.98M | 11.07M | 15.68M | 21.89M | 30.04M | 32.32M | 39.23M |
Operating income | -14.05M | -12.06M | -10.71M | -10.96M | -10.84M | -13.87M | -2.22M | -18.55M | -27.63M | -38.43M |
Other income (expenses), net | -1.12M | 345.52K | -10.51K | 17.67K | -5.29M | -3.91M | 2.77M | -10.31M | -13.13M | -1.48M |
Income before tax | -15.17M | -11.71M | -10.72M | -10.94M | -16.16M | -17.78M | -14.30M | -28.75M | -35.72M | -42.69M |
Income tax expense | 2.03M | 16.04K | -81.73K | 707 | 2.74K | -4.06M | -648K | -436.05K | 2.68M | 2.37M |
Net income | -17.21M | -11.73M | -10.63M | -10.94M | -16.12M | 74.94M | -14.30M | -27.56M | -35.72M | -42.69M |
Earnings per share | ||||||||||
Basic EPS | -0.59 | -0.4 | -0.45 | -0.76 | -1.89 | 9.4 | -1.84 | -3.65 | -4.8 | -7.01 |
Diluted EPS | -0.59 | -0.4 | -0.45 | -0.76 | -1.89 | 9 | -1.84 | -3.65 | -4.8 | -7.01 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |